// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























486 Abstracts

Serum Alpha-Fetoprotein Level Per Total Tumor Volume as a Predictor of Hepatocellular Carcinoma Recurrence Following Resection

Yeshika Sharma - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Liver cancer

Alfa-fetoprotein

The Clinical and Pathological Features of Nonalcoholic Fatty Liver Disease in Non Diabetes Patient

Aiko Himeno - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Nonalcoholic fatty liver disease

Hyaluronic acid

HCC Surveillance Is Associated With Early Tumor Detection and Improved Survival: A Multi-Center United States Study

Neehar D. Parikh - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Liver cancer

N/A

Hepatocellular Carcinoma in South America: Predominance of Hepatitis C Etiology and Late Diagnosis

Esteban Gonzalez Ballerga - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Nonalcoholic fatty liver disease

N/A

Prognosis of Patients With Hepatocellular Carcinoma Is Extremely Poor in African Country

Edith N. Okeke - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Sorafenib

Low Levels of Circulating Angiopoietin-like 4 Protein are Associated With the Presence of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease

Sean Felix - Digestive Disease Week (DDW) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Nonalcoholic fatty liver disease

Alfa-fetoprotein

Efficacy of variable dose of gallic acid to combat chemically induced hepatocarcinogenesis by altering the hepatic proinflammatory cytokines and oxidative stress

Vikas Kumar - International Society for Biological Therapy of Cancer (SITC) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alkaline phosphatase

Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers - a phase I/II study in patients with advanced hepatocellular carcinoma

Malin Sternby - International Society for Biological Therapy of Cancer (SITC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Intuvax

Histologic Differentiation of Hepatocellular Carcinoma and Response to Transcatheter Arterial Chemoembolization

Nikunj Shah - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Nonalcoholic fatty liver disease

N/A

Significance of FDG-PET/CT in the Prediction for Early and Rapid Recurrence Beyond Milan Criteria After Resection or Radiofrequent Ablation Against Hepatocellular Carcinoma

Hiroka Yamago - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Clinical Significance of Wee1 Kinase Positive Human Hepatocellular Carcinoma (HCC)

Hikaru Nagahara - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Liver cancer

N/A

Procurement of Adult Liver Stem Cells From Mouse Liver Using a Rho-Associated Protein Kinase Inhibitor Y-27632

Ling Lin - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Y-27632

Sequential Serum AFP Levels in Patients With HCC Prior to Intervention Predicts Length of Survival

Geri Brown - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Associations Between Etiology, Tumor Extent, and Alpha Fetoprotein in Patients With Hepatocellular Carcinoma

Nasra H. Giama - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Liver cancer

N/A

Characteristics of Hepatocellular Carcinoma in Cirrhotics (Stage 4 Fibrosis) vs Non-Cirrhotics (Stage 0-2 Fibrosis)

Bharat Panuganti - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Liver cancer

N/A

Machine Learning Algorithms Outperform Conventional Regression Models in Identifying Risk Factors for Hepatocellular Carcinoma in Patients With Cirrhosis

Akbar K. Waljee - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Failure Rates in a Surveillance Program for Hepatocellular Carcinoma Among Patients in the HALT-C Trial

Mahendra Nehra - Digestive Disease Week (DDW) , 2012

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Liver cancer

N/A

Differential diagnosis of ACTH-dependent Cushin-s syndrome: a case report

Tassiane Cintra Alvarenga Oliveira - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Addison's disease

Dexamethasone

A 23 year old female with Mixed Germ Cell and Embryonal Cell Carcinoma of the Pituitary Infundibulum: Lymphocytic Infundibulitis Versus Germ Cell Neoplasm- a Clinical and Pathological Conundrum

Hussain Mahmud - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Germ cell tumor

Human chorionic gonadotropin

An Unusual Case of Hypercalcemia of Unknown Mechanism in Advanced Chronic Liver Disease

Khin Ma - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Liver cancer

Spironolactone

Copyright © 2026. QuantiNova All rights reserved